Therapeutic Benefits of Lenalidomide in Hematological Malignancies

Lenalidomide is an immunomodulatory agent, which has action against most of the hematological malignancies. Apart from its immunomodulation, it has other properties such as antiproliferation and antiangiogenesis. It is not only effective in myelodysplastic syndromes and myeloma, recent studies show...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed Shafi Abdulsalam, Durai Mavalavan Vasudevan Manimoliyan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-04-01
Series:Indian Journal of Medical Specialities
Subjects:
Online Access:https://journals.lww.com/10.4103/INJMS.INJMS_8_19
Tags: Add Tag
No Tags, Be the first to tag this record!